Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 38.48 M41.09 M42.88 M47.6 M55.3 M55.7 M 201.49 M Research & development 24.22 M22.56 M24.43 M23.56 M23.95 M24.07 M 96 M Operating income 17.06 M24.01 M23.86 M17.77 M11.29 M10.69 M 63.6 M Non-Operating Income, Total -11.42 M-17.43 M339 K-4.54 M-1.04 M-75 K -5.31 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses -10.3 M-17.43 M339 K-1.02 M-1.06 M-237 K -1.98 M Unusual income/expense -1.12 M00-3.52 M22 K162 K -3.33 M Pretax income 2.08 M2.53 M20.88 M10.33 M7.61 M7.32 M 46.16 M Equity in earnings —————— — Taxes 2.21 M2.06 M5.93 M7.35 M3.4 M2.9 M 19.58 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -128 K477 K14.95 M2.99 M4.22 M4.42 M 26.57 M Discontinued operations —————— — Net income -128 K477 K14.95 M2.99 M4.22 M4.42 M 26.57 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -128 K477 K14.95 M2.99 M4.22 M4.42 M 26.57 M Basic earnings per share (Basic EPS) 00.020.490.090.140.14 0.86 Diluted earnings per share (Diluted EPS) 00.020.490.080.140.14 0.85 Average basic shares outstanding 30.78 M30.6 M30.48 M30.59 M30.52 M30.65 M — Diluted shares outstanding 30.78 M30.65 M30.75 M30.93 M30.76 M31.05 M — EBITDA —————— — EBIT 13.51 M19.97 M20.55 M14.87 M8.65 M7.4 M 51.47 M Cost of revenue 267.39 M285.33 M291.72 M291.99 M296.48 M319.74 M 1.2 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —